Annonce

Log ud Log ind
Log ud Log ind
Ledelse

US regulator: Foreløbige testdata fra AstraZeneca vildledende, kritiserer pressemeddelelse fra selskabet

Morten W. Langer

tirsdag 23. marts 2021 kl. 16:54

Fra Zerohedge:

During an interview where the good doctor also reassured the public that the troubled AstraZeneca COVID jab is still “a very good vaccine”, Dr. Anthony Fauci, senior advisor to President Biden, head of the NIAID, and head of the US delegation to the WHO, warned that Europe’s third wave could portend another surge in infections in the US.

With cases rising week over week in more than half of US states, and reports about the AstraZeneca trial data baffling the public, Dr. Fauci appeared on “Good Morning America” Tuesday to try and explain exactly what is going on.

Fauci started by assuring his audience that he was “optimistic” about the AstraZeneca vaccines’ effectiveness and expressed hope that AstraZeneca’s vaccine would soon join the other three approved for use in the US.

As for the AstraZeneca vaccine, Dr. Fauci explained during the interview that the DSMB, the agency overseeing all the COVID vaccine trials in the US, became incensed after it saw AstraZeneca publish a press release outlining the main findings from the trial data. That release – which the company later admitted was based on an “interim analysis” – was apparently seen as unsuitably premature by the regulator, which angrily rebuked AstraZeneca in “a rather harsh note” saying they thought the data in the press release “was somewhat outdated and might in fact be misleading a bit” – according to Dr. Fauci’s description (he said he had been copied on the email between the DSMB and AstraZeneca).

He concluded that releasing the data prematurely was “an unforced error” on AstraZeneca’s part, but that the jab would nonetheless be proven reliable and safe.

While Dr. Fauci’s attempt to explain away the latest AstraZeneca controversy took up most of the interview, the Associated Press noted that Dr. Fauci also warned about a surge in US cases.

Although vaccinations have eclipsed 105MM in the US and are continuing to climb at a staggering pace of more than 2M per day, an uptick in new cases, coinciding with genetic sequencing showing infectious mutated strains are responsible for much of the spread, has got policymakers worried. As more states reduce COVID lockdown restrictions, or abandon them entirely, many fear the US numbers could rise, following a pattern seen in Europe.

After Fauci’s stint on the popular morning show, GMA moved on to another story that might help explain all the panic about rising case numbers: pretty soon, the card people receiving displaying proof that they have received their COVID jabs might be more used for more than taking selfies. Pretty soon, proof of vaccination could become like a hall pass for life, permitting bearers to access everything from air travel to dine-in seating. But to justify this, governments need people to keep taking vaccines – and right now, demand far outstrips supply.

Få dagens vigtigste
økonominyheder hver dag kl. 12

Bliv opdateret på aktiemarkedets bevægelser, skarpe indsigter
og nyeste tendenser fra Økonomisk Ugebrev – helt gratis.

Jeg giver samtykke til, at I sender mig mails med de seneste historier fra Økonomisk Ugebrev.  Lejlighedsvis må I gerne sende mig gode tilbud og information om events. Samtidig accepterer jeg ØU’s Privatlivspolitik. Du kan til enhver tid afmelde dig med et enkelt klik.

[postviewcount]

Jobannoncer

SUN-AIR i Billund søger en kreditorbogholder
Region Syddanmark
Finansiel controller med stærk forretningsforståelse
Region Sjælland
Financial Controller til HMF Group A/S
Region Midt
Udløber snart
Dansk Sygeplejeråd søger en regnskabskonsulent med digitalt mindset og med erfaring i regnskabsprocessen fra A-Z (barselsvikariat)
Region Hovedstaden

Mere fra ØU Ledelse

Log ind

Har du ikke allerede en bruger? Opret dig her.

*Tilbuddet gælder ikke, hvis man har været abonnent indenfor de seneste 6 måneder

Tilmeld dig vores nyhedsbrev

Og modtag ØU’s rapport om Top 40 Ledelseskonsulenter gratis.

FÅ VORES STORE NYTÅRSUDGAVE AF FORMUE

Her er de 10 bedste aktier i 2022

Tilbuddet udløber om:
dage
timer
min.
sek.

Analyse af og prognoser for Fixed Income (statsrenter og realkreditrenter)

Direkte adgang til opdaterede analyser fra toneangivende finanshuse:

Goldman Sachs

Fidelity

Danske Bank

Morgan Stanley

ABN Amro

Jyske Bank

UBS

SEB

Natixis

Handelsbanken

Merril Lynch 

Direkte adgang til realkreditinstitutternes renteprognoser:

Nykredit

Realkredit Danmark

Nordea

Analyse og prognoser for kort rente, samt for centralbankernes politikker

Links:

RBC

Capital Economics

Yardeni – Central Bank Balance Sheet 

Investing.com: FED Watch Monitor Tool

Nordea

Scotiabank